| Code | CSB-RA007205MB1HU |
| Size | |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody described in US010696743B2, specifically targeting desmoglein 3 (DSG3). DSG3 is a calcium-binding transmembrane glycoprotein and a critical component of desmosomes, which are cell-cell adhesion structures that maintain tissue integrity in stratified epithelia. This protein is predominantly expressed in mucosal tissues and plays an essential role in keratinocyte adhesion. DSG3 is clinically significant as the primary autoantigen in pemphigus vulgaris, a severe autoimmune blistering disorder characterized by loss of keratinocyte adhesion. Additionally, DSG3 has emerged as an important factor in cancer research, with altered expression patterns observed in various squamous cell carcinomas and implications for tumor progression and metastasis.
The reference antibody serves as a valuable tool for investigating DSG3-mediated cellular adhesion mechanisms, autoimmune pathogenesis in pemphigus disorders, and the role of desmosomal proteins in epithelial biology. This biosimilar antibody provides researchers with a reliable reagent for studying DSG3 function in normal physiology and disease contexts, including autoimmunity and oncology research.
There are currently no reviews for this product.